Trial
NCT03624101
Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Cystic Fibrosis
Intervention
Symdeko
Why stopped
summary results revealed ineffective intervention and the trial was terminated prematurely. No formal statistical analysis was performed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-16